Facebook Linkedin Twitter
Inside Precision Medicine Lilly Pays up to $2.5B for Selective PI3Kα Inhibitor  

Eli Lilly and Company

woman lymph armpit examination. Node-Positive Breast Cancer
News & Features

Lilly Pays up to $2.5B for Selective PI3Kα Inhibitor  

0
Image showing the translation of a protein with the help of tRNA and ribosomes
Informatics

AI Proteins Inks Potential $400M Deal with BMS for AI Drug Discovery

0
Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).
News & Features

Lipoprotein(a) Lowering Draw Between Lilly and Silence

0
The New York Times, June 27, 2000
News & Features

Personalized Medicine: Past, Present, and Future

Edward Abrahams, PhD
0
Nerve cells affected by Alzheimer's disease, which may involve abnormal microglia cells.
News & Features

AbbVie Acquires Aliada and Alzheimer’s Candidate for $1.4B 

0
woman lymph armpit examination. Node-Positive Breast Cancer
News & Features

Kisqali Nets FDA Expanded Approval in Early Breast Cancer

0
Transparent blue image of human heart with monitored beat, which can be abnormal in people with long QT syndrome
News & Features

Lilly’s Tirzepatide Improves Heart Failure Outcomes

0
The glucagon like peptide-1 ( GLP-1) receptor , activated complex with an agonist (semaglutide) and G-proteins
Informatics

Tirzepatide Tops Semaglutide for Weight Loss in Type 2 Diabetes

0
Weight loss pills and unhealthy dieting with medication concept
News & Features

Precision Medicine for Obesity: Targeting a Multifactorial Condition

Helen Albert
0
Picture of protein structure used to illustrate AlphaFold database release
Informatics

DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released 

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine